Form 4 for CGEM Cullinan Therapeutics, Inc.
Accepted 2024-05-23 00:00:00 ET · period of report 2024-05-23 · accession 0000950170-24-063948 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-23 | 2024-05-23 | CGEM | Ebeling Thomas | Dir | A - Grant | $5.68 | +100.7K | 168.2K | +149% | +$571.9K |
| DM | 2024-05-23 | 2024-05-23 | CGEM | Ebeling Thomas | Dir | M - OptEx | $0.00 | -100.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-23 | A | A | 84,224 | $4.30 | 151,728 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-23 | A | A | 16,475 | $12.73 | 168,203 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-05-23 | M | D | 84,224 | $0.00 | 0 | D | $4.30 · — to 2030-10-28 | 84,224 Common Stock | (F1) 25% of the shares vested on August 16, 2018, and the remaining shares vested in 36 equal monthly installments thereafter. |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-05-23 | M | D | 16,475 | $0.00 | 0 | D | $12.73 · 2023-06-08 to 2032-06-21 | 16,475 Common Stock |